12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Benzhydrocodone regulatory update

KemPharm said it completed an end-of-Phase II meeting with FDA and now plans to submit an NDA to FDA in 3Q14 for KP201 to...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >